David D.
- Country
- Czechia
- Department
- Neurology
Research Overview
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Botulinum Toxin Type A in Preventing Episodic Migraine in Adults: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 113 of 249 partner sites.
Specializations
Migraine Research
This investigator specializes in various forms of migraine disorders, including extensive work in both chronic and episodic migraine treatments. Their research encompasses menstrual migraine and preventative therapeutic approaches.
- Chronic Migraine Prevention
- Episodic Migraine Management
- Menstrual Migraine Treatment
The investigator explores both established and novel therapeutic agents for migraine prevention and acute treatment.
Neuropathic Pain Studies
The investigator conducts research in diabetic peripheral neuropathic pain, focusing on innovative treatment approaches and pain management strategies.
- Diabetic Neuropathy Treatment
- Chronic Pain Management
- Novel Pain Therapeutics
Their work includes evaluation of various therapeutic modalities, including medical cannabis and specialized pain medications.
Treatment Innovations
The investigator evaluates preventative treatments and acute interventions across neurological conditions, with particular attention to treatment-resistant cases.
- Novel Therapeutic Agents
- Long-term Treatment Efficacy
- Alternative Treatment Approaches
Research focuses on both established medications and emerging therapeutic options for neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.